Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial
Egile Nagusiak: | , , , , , , , , , , , |
---|---|
Formatua: | Conference item |
Argitaratua: |
2010
|
Gaia: |
---|